143 related articles for article (PubMed ID: 16421945)
1. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.
Zhang T; Somasundaram R; Berencsi K; Caputo L; Gimotty P; Rani P; Guerry D; Swoboda R; Herlyn D
Eur J Immunol; 2006 Feb; 36(2):457-67. PubMed ID: 16421945
[TBL] [Abstract][Full Text] [Related]
2. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
Berencsi K; Meropol NJ; Hoffman JP; Sigurdson E; Giles L; Rani P; Somasundaram R; Zhang T; Kalabis J; Caputo L; Furth E; Swoboda R; Marincola F; Herlyn D
Cancer Immunol Immunother; 2007 Mar; 56(3):359-70. PubMed ID: 16783574
[TBL] [Abstract][Full Text] [Related]
3. CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
Zhang T; Somasundaram R; Berencsi K; Caputo L; Rani P; Guerry D; Furth E; Rollins BJ; Putt M; Gimotty P; Swoboda R; Herlyn M; Herlyn D
J Immunol; 2005 May; 174(9):5856-63. PubMed ID: 15843590
[TBL] [Abstract][Full Text] [Related]
4. Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes.
Wang H; Nemoto-Sasaki Y; Kondo T; Akiyama M; Mukaida N
Int Immunopharmacol; 2003 May; 3(5):627-42. PubMed ID: 12757733
[TBL] [Abstract][Full Text] [Related]
5. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
Berencsi K; Rani P; Zhang T; Gross L; Mastrangelo M; Meropol NJ; Herlyn D; Somasundaram R
J Transl Med; 2011 Mar; 9():33. PubMed ID: 21450101
[TBL] [Abstract][Full Text] [Related]
6. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.
Ishida T; Ishii T; Inagaki A; Yano H; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Res; 2006 Jun; 66(11):5716-22. PubMed ID: 16740709
[TBL] [Abstract][Full Text] [Related]
7. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
[TBL] [Abstract][Full Text] [Related]
8. Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.
Zhang T; Somasundaram R; Berking C; Caputo L; Van Belle P; Elder D; Czerniecki B; Hotz S; Schuchter L; Spitz FR; Berencsi K; Rani P; Marincola F; Qiu R; Herlyn D
Cancer Biol Ther; 2006 Oct; 5(10):1304-12. PubMed ID: 16929176
[TBL] [Abstract][Full Text] [Related]
9. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
10. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
[TBL] [Abstract][Full Text] [Related]
11. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
[TBL] [Abstract][Full Text] [Related]
12. Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.
Kondo T; Takiguchi M
Int Immunol; 2009 May; 21(5):523-32. PubMed ID: 19261691
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway.
Penido C; Costa MF; Souza MC; Costa KA; Candéa AL; Benjamim CF; Henriques Md
Int Immunol; 2008 Jan; 20(1):129-39. PubMed ID: 18056919
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
[TBL] [Abstract][Full Text] [Related]
16. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
Hu K; Xiong J; Ji K; Sun H; Wang J; Liu H
Immunol Lett; 2007 Oct; 113(1):19-28. PubMed ID: 17868906
[TBL] [Abstract][Full Text] [Related]
17. Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production.
Shiratsuchi Y; Iyoda T; Tanimoto N; Kegai D; Nagata K; Kobayashi Y
J Leukoc Biol; 2007 Feb; 81(2):412-20. PubMed ID: 17095610
[TBL] [Abstract][Full Text] [Related]
18. CCL2 as a trigger of manifestations of compensatory anti-inflammatory response syndrome in mice with severe systemic inflammatory response syndrome.
Takahashi H; Tsuda Y; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2006 Apr; 79(4):789-96. PubMed ID: 16434696
[TBL] [Abstract][Full Text] [Related]
19. CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.
Mullins IM; Slingluff CL; Lee JK; Garbee CF; Shu J; Anderson SG; Mayer ME; Knaus WA; Mullins DW
Cancer Res; 2004 Nov; 64(21):7697-701. PubMed ID: 15520172
[TBL] [Abstract][Full Text] [Related]
20. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Zheng M; Sun G; Cai S; Mueller R; Mrowietz U
Chin Med J (Engl); 1999 Jun; 112(6):493-6. PubMed ID: 11601324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
